Celecoxib EP Impurity B
![](https://alentris.org/wp-content/uploads/ALN-C005003-1.png)
Product Description
CAT No.
ALN-C005003
CAS No.
331943-04-5
Mol. F.
C17H14F3N3O2S
Mol. Wt.
381.4
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 4-[3-(4-Methylphenyl)-5-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide
Smiles : O=S(C1=CC=C(N2N=C(C3=CC=C(C)C=C3)C=C2C(F)(F)F)C=C1)(N)=O
Inchi : InChI=1S/C17H14F3N3O2S/c1-11-3-2-4-12(9-11)15-10-16(17(18,19)20)22-23(15)13-5-7-14(8-6-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)
Synonym : Celecoxib USP Related Compound B
Technical Data
Reference
Development of a Unified Reversed-Phase HPLC Method for Efficient Determination of EP and USP Process-Related Impurities in Celecoxib Using Analytical Quality by Design Principles
Tim Tome, Zdenko u010casar ,OrcID andAleu0161 ObrezanMolecules 2020, 25(4), 809
A selective and sensitive LC-MS/MS method for the simultaneous determination of twopotential genotoxic impurities in celecoxib
Ambavaram Vijaya Bhaskar Reddy, Nandigam Venugopal & Gajulapalle Madhavi – Journal of Analytical Science and Technology volume 5, Article number: 18 (2014)
Stability-Indicating HPLC Method for Quantification of Celecoxib and Diacerein Along With Its Impurities in Capsule Dosage Form
Hanimi Reddy Bapatu, Ravi Kumar Maram, R. Satyanarayana Murthy – Journal of Chromatographic Science, Volume 53, Issue 1, January 2015, Pages 144–153
RFQ